The integration of cutting-edge technologies like artificial intelligence and medical robotics into clinical diagnostics is driving breakthroughs in early lung cancer screening and precision treatment. Recently, the First Affiliated Hospital of Guangzhou University of Chinese Medicine introduced an AI-powered thoracic surgery robot, which utilizes AI to precisely locate small lung nodules. This upgrades the traditional approach from "blind searching" to "targeted precision," significantly enhancing the efficiency of early lung cancer diagnosis and treatment, while offering patients more accurate and minimally invasive therapeutic options.

Data shows that lung cancer remains one of the malignancies with the highest morbidity and mortality rates in China. However, early detection and treatment can substantially improve patient survival rates. Traditional localization of small lung nodules relies on repeated CT scans, which are not only time-consuming but also prone to positioning errors. In contrast, AI navigation combined with robotic-assisted technology enables precise single-shot localization, shortening surgery time, reducing trauma, and maximizing the preservation of healthy lung tissue. This provides a new technical pathway for early diagnosis and treatment of lung cancer.

Industry insiders believe that as technologies such as AI image recognition, 3D reconstruction, and robotic-assisted interventions continue to mature, the medical robotics industry is accelerating into a phase of commercial application. This covers high-value fields including lung cancer, orthopedics, and neurosurgery, offering vast growth potential. Benefiting from the trend of medical intelligence upgrades, TH MEDICAL-B (02697), known as the "first puncture surgery robot stock," is steadily advancing its layout in artificial intelligence and digital healthcare. The company is continuously refining its product portfolio in areas such as smart healthcare, AI-assisted diagnosis, and medical informatization, actively promoting the application of AI technology in hospital clinical settings. As the nation pushes forward with medical digitalization and new technologies like AI medical robots and precision diagnostics accelerate their implementation, TH MEDICAL-B is poised to benefit from rising industry prosperity, further unlocking long-term growth potential.